GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
Friday Market Rebounds Some of Weeks Loss | Wall Street Today
12 Health Care Stocks Moving In Friday's Pre-Market Session
Pfizer Gets FDA Accelerated Approval for Braftovi
What's Going On With Amgen Stock On Friday?
FDA Grants Accelerated Approval To Encorafenib With Cetuximab And MFOLFOX6 For Metastatic Colorectal Cancer With A BRAF V600E Mutation
hardeep dhaliwal : Based on Company’s financial Statements it will fly….